Legal status · Canada
Is Neuropeptide Y legal in Canada?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
No. Neuropeptide Y is not an approved medicine in Canada; its classification is "Not a medicine; endogenous signalling molecule". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 3 human studies are cited on its profile.
Neuropeptide Y in Canada at a glance
| Classification | Not a medicine; endogenous signalling molecule |
|---|---|
| Note | No approved NPY or NPY receptor medicine. |
| Health Canada approval status | Not approved by Health Canada |
| Human studies cited | 3 of 5 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the Neuropeptide Y profile, checked against Health Canada, Health Products and Food Branch (Health Canada) listings at the reviewed date.
What this means
- 01
No product containing Neuropeptide Y is approved by Health Canada for any use in Canada, so nothing on the market is authorized for people.
- 02
"Research use only" is a vendor label, not a legal category that permits human use. It does not exempt a product from medicines law.
- 03
Importing, supplying or promoting it for human use can fall under medicines legislation in Canada. This page is general information, not legal advice.
What Neuropeptide Y is
The most potent appetite-driving peptide known when injected into a rodent brain. The one large human test of the idea, a 52 week trial of a Y5 receptor blocker in 1,661 overweight and obese adults, produced weight loss its own authors called not clinically meaningful. The only trial of NPY itself in people gave it intranasally to 26 patients with PTSD.
Neuropeptide Y is one of the most abundant neuropeptides in the mammalian brain and a co-transmitter released alongside noradrenaline from sympathetic nerves. It is a 36 amino acid peptide and it belongs to one structural family with peptide YY and pancreatic polypeptide, which is why the three are almost always discussed together.
Mechanism: NPY signals through a family of class A G protein-coupled receptors. In humans, Y1, Y2, Y4 and Y5 are functional.
Regulatory history: NPY is an endogenous neuropeptide, not a drug, and there is no approved product containing it. No drug acting at any NPY receptor is approved for obesity or for any other indication. Intranasal NPY has been studied in a phase 1 trial in PTSD.
How Health Canada treats this kind of product
Authorises drugs for sale through a Notice of Compliance and Drug Identification Number. A compound that is not authorised for sale cannot lawfully be sold for human use, and personal importation of prescription drugs is limited.
The classification above is the The Longevity Archive reading of Health Canada, Health Products and Food Branch listings for Neuropeptide Y at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Neuropeptide Y in other countries
United States
Not approvedNot a medicine; endogenous signalling molecule
Is Neuropeptide Y legal in the United States?United Kingdom
Not approvedNot a medicine; endogenous signalling molecule
Is Neuropeptide Y legal in the United Kingdom?Australia
Not approvedNot a medicine; endogenous signalling molecule
Is Neuropeptide Y legal in Australia?Frequently asked questions
Is Neuropeptide Y legal in Canada?
No. Neuropeptide Y is not an approved medicine in Canada; its classification is "Not a medicine; endogenous signalling molecule". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 3 human studies are cited on its profile. Note: No approved NPY or NPY receptor medicine.
Can I buy Neuropeptide Y in Canada?
No approved product exists to buy. In Canada Neuropeptide Y is classified as "Not a medicine; endogenous signalling molecule", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors. Note: No approved NPY or NPY receptor medicine.
Is Neuropeptide Y Health Canada approved?
No. In Canada Neuropeptide Y is classified as "Not a medicine; endogenous signalling molecule", which is not a Health Canada marketing approval. For comparison, the US FDA status is: NPY is an endogenous neuropeptide, not a drug, and there is no approved product containing it. No drug acting at any NPY receptor is approved for obesity or for any other indication. Intranasal NPY has been studied in a phase 1 trial in PTSD.. On the evidence, 3 human studies are cited on its profile.
Related compounds in Canada
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Neuropeptide Y live on its compound profile.
Neuropeptide Y profileThis page is general information about the regulatory status of Neuropeptide Y in Canada, current as of Sep 2026. It is not legal advice, and classifications change; check Health Canada, Health Products and Food Branch directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.